DKK3 as a novel biomarker for risk stratification in pediatric acute lymphoblastic leukemia
DKK3 shows promise as a biomarker for early risk stratification and prognosis prediction in pediatric ALL, potentially supporting personalized treatment strategies.
Authors
- Feng Zhu (ORCID: https://orcid.org/0000-0002-6360-4384)
- Ying Chang (ORCID: https://orcid.org/0000-0003-4016-6200)
- JiZhao Gao
- Lihui Lu
- Lei Guo (ORCID: https://orcid.org/0000-0003-0728-896X)
- Zhiyong Li (ORCID: https://orcid.org/0000-0002-6814-9165)
- Pei Li (ORCID: https://orcid.org/0000-0002-2870-7484)
- Yung‐Ming Chen (ORCID: https://orcid.org/0000-0002-9241-1258)
- Wenpeng Wang (ORCID: https://orcid.org/0000-0002-1151-7203)
- Bi Zhou (ORCID: https://orcid.org/0000-0002-8943-845X)
- DaWei Mi
Institutions
- Xuzhou Medical College (CN)
- Anhui Medical University (CN)
- Suzhou Municipal Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1080/16078454.2025.2585255
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00